Device / Technology News

RSS

Telit CC864-DUAL cellular module to connect next generation MCOT from CardioNet

Telit Wireless Solutions, a global leader in machine-to-machine (M2M) wireless technology, today announced its CC864-DUAL cellular module will connect the next generation Mobile Cardiac Outpatient Telemetry (MCOT) from CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias.

9 May 2012

IBN develops biochip for investigating the effect of drugs on cancer stem cells

Researchers at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a miniaturized biochip for investigating the effect of drugs on cancer stem cells (CSCs). Published recently in Nano Today, this new technology could boost the development of more effective cancer drugs.

9 May 2012

U of A marks National Nursing Week with launch of online palliative care toolkit

An interactive toolkit created by a team from the University of Alberta helps palliative care patients and their care providers to deal with the physical, emotional and relationship changes that come with terminal and chronic illnesses.

9 May 2012

Medtronic’s Valiant Captivia Stent Graft now available in seven countries

Increasing patient access to endovascular repair of aortic aneurysms worldwide, Medtronic, Inc. is expanding availability of the Valiant Captivia Thoracic Stent Graft System in several countries, including China, Japan and the United States.

From Medtronic 9 May 2012

Vascular Closure Systems completes FastSeal Phase I FIH clinical trial

The company is pleased to announce that after receiving Ethical Committee (EC) and Ministry of Health (MOH) approval, for the first human use of the company's FastSeal Bioabsorbable Vascular Access Closure System, Phase I of the First in Human (FIH) clinical testing has been completed, with 100% successful results, and no adverse effects, including post procedural discomfort.

9 May 2012

Domain Surgical's FMwand successfully used in 100 cases

Domain Surgical, a leading developer of advanced thermal surgical technology, today announced that its novel FMwand Ferromagnetic Surgical System has been used successfully in 100 cases. The FMwand simultaneously cuts and coagulates tissue without passing electrical current into the patient, making it safe to use near delicate tissue structures.

9 May 2012

Sorin launches FDA-approved PARADYM RF family of ICDs and CRT-D devices

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, FDA approval and commercial launch of the PARADYM RF family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) devices.

9 May 2012

eTNS therapy can impact symptoms in pharmacoresistant major depression

Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.

9 May 2012

Stereotaxis launches V-Sono module for Vdrive Remote Navigation System

Stereotaxis, Inc. today announced that the Company has released to the European market the V-Sono intracardiac echocardiography manipulator module for the Vdrive Remote Navigation System.

9 May 2012

UVA achieves two important milestones in VISIUS Surgical Theatre

IMRIS Inc. today reported on the preliminary successes that the University of Virginia (UVA) has achieved in their VISIUS Surgical Theatre. UVA clinicians have treated over 50 patients in their VISIUS Surgical Theatre since its opening, achieving two important milestones in the use of their new intraoperative imaging capabilities.

9 May 2012

iBio receives U.S. patent for iBioModulator platform

iBio, Inc. today announced issuance of a US patent covering compositions of matter and methods of use of modified lichenase B polypeptides comprising the Company's iBioModulator platform.

9 May 2012

FDA clears Hitachi’s Echelon Oval 1.5T Ultra-Wide MR system

Hitachi Medical Systems America, Inc., a leading provider of diagnostic imaging equipment, announced FDA clearance to market its Echelon Oval 1.5T Ultra-Wide MR system.

9 May 2012

Bacterin International announces third national GPO contract with Novation

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces its third national GPO contract, a three-year agreement with Novation, a leading health care supply chain expert and contracting company.

8 May 2012

Covidien to unveil new OneShot renal denervation system at EuroPCR congress

Covidien, a leading global provider of healthcare products, will unveil its new OneShot renal denervation system at the EuroPCR congress in Paris, France, on May 16, 2012. Adding to the Company's broad and growing vascular therapies portfolio, the OneShot system is designed to treat patients with hypertension who are not responsive to traditional medical therapy.

8 May 2012

FDA approves St. Jude Medical's Assura family of implantable defibrillators

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

8 May 2012

Cellular-level images of the living eye

The same technology used by astronomers to obtain clear views of distant stars is now being used by optometrists to perform incredibly detailed examinations of the living eye.

8 May 2012

LAA occlusion effectively reduces risk of stroke in patients with A-fib

Patients with atrial fibrillation (A-fib) who cannot take blood thinners now have an alternative to reduce their risk of stroke, which is five times more common in people with the rhythm disorder. The non-surgical procedure works by tying off the left atrial appendage (LAA), the source of most blood clots leading to stroke in patients with A-fib. Northwestern Medicine- heart rhythm specialists from the Bluhm Cardiovascular Institute were the first to perform this procedure in Illinois.

8 May 2012

ABIM approves AGA’s Procedural Sedation/Patient Safety PIM

The American Gastroenterological Association (AGA) Institute's Procedural Sedation/Patient Safety Practice Improvement Module (PIM) has received approval from the American Board of Internal Medicine (ABIM) to be part of ABIM's Approved Quality Improvement (AQI) Pathway.

8 May 2012

Autism Speaks launches automated M-CHAT tool

Autism Speaks is pleased to announce the launch of an automated version of the Modified Checklist for Autism in Toddlers, or M-CHAT.

8 May 2012

Stereotaxis to highlight results from Epoch clinical study at HRS annual meeting

Stereotaxis, Inc. will highlight clinical results from the first 1,250 cases and the latest innovations for the Epoch platform, its new generation comprehensive solution for the electrophysiology (EP) laboratory, at the 33rd Annual Heart Rhythm Society (HRS) Scientific Sessions, May 9-12, 2012.

8 May 2012